Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | CTNNB1 | P35222 | 2/20 | 0.35 |
| ▸ | WNT3A | P56704 | 2/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15901993 | 0.64 | MEN1 (0.41) | ALDH1A1MEN1GAAKMT2ANPC1 | |
| SCHEMBL15902089 | 0.64 | KDM4E (0.41) | ALDH1A1NPC1RAB9AHSD17B10 | |
| SCHEMBL984268 | 0.62 | PIN1 (0.52) | ALDH1A1RAB9ASMN1; SMN2HPGDALOX15 | |
| SCHEMBL703854 | 0.62 | CTNNB1 (0.65) | ALDH1A1MEN1GAAKMT2ANPC1 | |
| SCHEMBL9286289 | 0.61 | HCAR2 (0.33) | — | |
| Hydrochloric Acid SCHEMBL27928599 | 0.61 | PIN1 (0.51) | ALDH1A1RAB9ASMN1; SMN2HPGDALOX15 | |
| SCHEMBL27755564 | 0.61 | PIN1 (0.51) | ALDH1A1RAB9ASMN1; SMN2HPGDALOX15 | |
| Hydrochloric Acid SCHEMBL27755478 | 0.61 | PIN1 (0.51) | ALDH1A1RAB9ASMN1; SMN2HPGDALOX15 | |
| SCHEMBL15902280 | 0.60 | PIN1 (0.36) | ALDH1A1MEN1GAAKMT2ANPC1 | |
| SCHEMBL8980290 | 0.60 | PIN1 (0.39) | ALDH1A1MEN1GAAKMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140213538-A1 | LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | INTERMUNE, INC. | 2014-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140213538-A1 | LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | LPAR1, LPAR2, LPAR5 | ALDH1A1 4135/4885MEN1 1384/4885GAA 957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.